The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Open accessAbstract
The inflammatory nature of atherosclerosis is well established but the agent(s) that incite inflammation in the artery wall remain largely unknown. Germ-free animals are susceptible to atherosclerosis, suggesting that endogenous substances initiate the inflammation. Mature atherosclerotic lesions contain macroscopic deposits of cholesterol crystals in the necrotic core, but their appearance late in atherogenesis had been thought to disqualify them as primary inflammatory stimuli. However, using a new microscopic technique, we revealed that minute cholesterol crystals are present in early diet-induced atherosclerotic lesions and that their appearance in mice coincides with the first appearance of inflammatory cells. Other crystalline substances can induce inflammation by stimulating the caspase-1-activating NLRP3 (NALP3 or cryopyrin) inflammasome, which results in cleavage and secretion of interleukin (IL)-1 family cytokines. Here we show that cholesterol crystals activate the NLRP3 inflammasome in phagocytes in vitro in a process that involves phagolysosomal damage. Similarly, when injected intraperitoneally, cholesterol crystals induce acute inflammation, which is impaired in mice deficient in components of the NLRP3 inflammasome, cathepsin B, cathepsin L or IL-1 molecules. Moreover, when mice deficient in low-density lipoprotein receptor (LDLR) were bone-marrow transplanted with NLRP3-deficient, ASC (also known as PYCARD)-deficient or IL-1alpha/beta-deficient bone marrow and fed on a high-cholesterol diet, they had markedly decreased early atherosclerosis and inflammasome-dependent IL-18 levels. Minimally modified LDL can lead to cholesterol crystallization concomitant with NLRP3 inflammasome priming and activation in macrophages. Although there is the possibility that oxidized LDL activates the NLRP3 inflammasome in vivo, our results demonstrate that crystalline cholesterol acts as an endogenous danger signal and its deposition in arteries or elsewhere is an early cause rather than a late consequence of inflammation. These findings provide new insights into the pathogenesis of atherosclerosis and indicate new potential molecular targets for the therapy of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Oxidized low-density lipoprotein (LDsL), a cholesterol carrier, can also form crystals within lysosomes after internalization [74].”
From HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV (2025) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Elevation of CEs and BMPs was also observed in LOAD patients’ EC, suggesting disease relevance.43”
From Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist (2024) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“Oxidized low‐density lipoprotein and cholesterol crystals activate the inflammasome, thereby leading to the processing and secretion of the proinflammatory cytokines IL‐1β and IL‐18 and ultimately triggering vascular inflammation via upregulation of adhesion molecules.9, 10”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [10]
In the citing paper
“AS is decreased in several rodent models lacking NLRP3 or IL‐1 molecules, whereas in contrast, mice deficient in the IL‐1 receptor antagonist show increased AS.10”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [10]
In the citing paper
“These results clearly indicate that the NLRP3 inflammasome plays a key role in the pathogenesis of vascular inflammation, thereby contributing to AS development.”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [10]
In the citing paper
“Inhalation of crystalline silica can induce inflammation by stimulating the NLRP3 inflammasome, a cytosolic receptor complex that plays a critical role in driving inflammatory immune responses.”
From Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages (2018) · cites this paper as [20]
In the citing paper
“The NLRP3 inflammasome senses crystalline danger signals that can occur during autoinflammatory diseases, such as gout or atherosclerosis, and environmental diseases, such as silicosis or asbestosis (18, 20, 22).”
From Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages (2018) · cites this paper as [20]
In the citing paper
“inflammasome-dependent cytokine synthesis and release is a two-step process that is initiated after ligation of TLRs and other receptors capable of binding DAMPS and/or MAMPs leading to NLRP3 gene transcription, translation, and protein production (Duewell et al, 2010).”
From Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders (2017) · cites this paper as Duewell et al, 2010
In the citing paper
“Urate and cholesterol crystals, as well as sterile particulates, for example, can bypass the requirement for ATP and P2RX7 for IL-1β production55,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“For these sterile particulates to activate NLRP3, they must be internalized, as blockade of endocytosis by the actin-depolymerizing drug cytochalasin D inhibited NLRP3-dependent IL-1β production58,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“Low-density lipoprotein (LDL) receptor-deficient mice, which are prone to developing atherosclerotic lesions, had lower IL-1β levels, smaller atherosclerotic lesions and less neutrophilic infiltration than wild-type mice when lethally irradiated and infused with NLRP3-deficient bone marrow59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“Lysosomal damage can occur during cellular injury and necrosis, and has also been associated with other sterile activators of NLRP3, such as cholesterol59 and silica crystals44.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,506
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
Self-citationHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Self-citationThe NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Cited by
Sorted by citations
Items 701–800 of 1,023
Robinson, P. C., Terkeltaub, R. A., Pillinger, M. H., Shah, B., Karalis, V. D., Karatza, E., Liew, D. F. L., Imazio, M., Cornel, J. H., Thompson, P. L., et al. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.07.025 · Cited by 127
Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation
Progatzky, F., Sangha, N. S., Yoshida, N., McBrien, M., Cheung, J. L. Y., Shia, A., Scott, J., Marchesi, J. R., Lamb, J. R., Bugeon, L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6864 · Cited by 126
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2014) · Acta Physiologica · doi:10.1111/apha.12438 · Cited by 125
“…inflammation by induction of NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasomes via phagolysosome damage and cytosolic release of cathepsin, a lysosomal endopeptidase that cleaves pro-IL-1b to active proinflammatory cytokine IL-1b (Duewell et al. 2010, Rajam€aki et al. 2010).”
BackgroundInfluentialMyeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis
Liu, Y., Carmona‐Rivera, C., Moore, E., Seto, N. L., Knight, J. S., Pryor, M., Yang, Z., Hemmers, S., Remaley, A. T., Mowen, K. A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01680 · Cited by 122
“Multiple studies have shown that IL-1β plays important roles in atherosclerosis (33, 34).”
BackgroundTrained Immunity: An Underlying Driver of Inflammatory Atherosclerosis
Zhong, C., Yang, X., Feng, Y., & Yu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00284 · Cited by 123
Gicquel, T., Robert, S., Loyer, P., Victoni, T., Bodin, A., Ribault, C., Gléonnec, F., Couillin, I., Boichot, E., & Lagente, V. (2015) · The FASEB Journal · doi:10.1096/fj.14-267393 · Cited by 133
Kong, F., Ye, B., Lü, L., Cai, X., Huang, W., & Huang, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.043 · Cited by 123
An, N., Gao, Y., Si, Z., Zhang, H., Wang, L., Tian, C., Yuan, M., Yang, X., Li, X., Shang, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01592 · Cited by 124
Animal Models of Atherosclerosis–Supportive Notes and Tricks of the Trade
Gisterå, A., Ketelhuth, D. F. J., Malin, S., & Hansson, G. K. (2022) · Circulation Research · doi:10.1161/circresaha.122.320263 · Cited by 127
DAMPs in the immunogenicity of cell death
Chen, R., Zou, J., Liu, J., Kang, R., & Tang, D. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.09.007 · Cited by 141
Ambiguities in NLRP3 inflammasome regulation: Is there a role for mitochondria?
Lawlor, K. E., & Vince, J. E. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.08.014 · Cited by 124
Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production
Ceneri, N. M., Zhao, L., Young, B. D., Healy, A. L., Coşkun, S., Vasavada, H. H., Yarovinsky, T. O., Ike, K., Pardi, R., Qin, L., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308507 · Cited by 120
Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen
Fang, J., Little, P. J., & Xu, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21438 · Cited by 122
Pyroptosis-Induced Inflammation and Tissue Damage
Wei, Y., Yang, L., Pandeya, A., Cui, J., Zhang, Y., & Li, Z. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167301 · Cited by 130
Yu, L., Hong, W., Lu, S., Li, Y., Guan, Y., Weng, X., & Feng, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.780496 · Cited by 126
A Novel Flow Cytometric Method To Assess Inflammasome Formation
Sester, D. P., Thygesen, S. J., Sagulenko, V., Vajjhala, P. R., Cridland, J. A., Vitak, N., Chen, K. W., Osborne, G. W., Schroder, K., & Stacey, K. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401110 · Cited by 119
Joshi, S. N., Wang, W., Peck, A. B., & Khan, S. R. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.11.093 · Cited by 120
An Expanding Role for Interleukin-1 Blockade from Gout to Cancer
Dinarello, C. A. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00232 · Cited by 127
Rashidi, M., Simpson, D. S., Hempel, A., Frank, D. O., Petrie, E. J., Vince, A. J., Feltham, R., Murphy, J., Chatfield, S. M., Salvesen, G. S., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900228 · Cited by 120
NLRP3 inflammasome signalling in Alzheimer's disease
McManus, R. M., & Latz, E. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109941 · Cited by 136
“Due to this, NLRP3 inflammasome activation has been found across many different and seemingly unconnected diseases, from atherosclerosis (Duewell et al., 2010), gout (Goldberg et al., 2017), multiple sclerosis (Coll et al., 2015) and AD (Heneka et al., 2013).”
Self-citationMASH: the nexus of metabolism, inflammation, and fibrosis
Steinberg, G. R., Carpentier, A. C., & Wang, D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186420 · Cited by 135
“…mitochondrial membrane integrity, impairing respiratory capacity and inducing mitochondrial damage, which promotes the release of mitochondrial DNA (mtDNA) (32), while cholesterol sequestration within lysosomes induces phagolysosomal damage (33) that leads to the release of cathepsins (34, 35).”
Bieghs, V., Verheyen, F., van Gorp, P. J., Hendrikx, T., Wouters, K., Lütjohann, D., Gijbels, M. J., Febbraio, M., Binder, C. J., Hofker, M. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034378 · Cited by 121
Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease
Chen, K., & Keaney, J. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0266-8 · Cited by 122
Complement‐induced activation of the cardiac NLRP3 inflammasome in sepsis
Kalbitz, M., Fattahi, F., Grailer, J. J., Jajou, L., Malan, E. A., Zetoune, F. S., Huber-Lang, M. S., Russell, M. W. W., & Ward, P. A. (2016) · The FASEB Journal · doi:10.1096/fj.201600728r · Cited by 121
Koppert, S., Büscher, A., Babler, A., Ghallab, A., Buhl, E. M., Latz, E., Hengstler, J., Smith, E. R., & Jahnen-Dechent, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01991 · Cited by 103
“) only provide the activation signal and require priming by an additional independent stimulus— usually achieved with microbial TLR agonists like LPS in vitro (29, 52, 53).”
BackgroundSelf-citationRovira‐Llopis, S., Apostolova, N., Bañuls, C., Muntané, J., Rocha, M., & Víctor, V. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7313 · Cited by 125
Nie, C., Ding, X., Rong, A., Zheng, M., Li, Z., Pan, S., & Yang, W. P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119248 · Cited by 120
A Critical Role for Human Caspase-4 in Endotoxin Sensitivity
Kajiwara, Y., Schiff, T., Voloudakis, G., Sosa, M. A. G., Elder, G. A., Bozdagi, O., & Buxbaum, J. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303424 · Cited by 119
Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy
Momtazi‐Borojeni, A. A., Abdollahi, E., Nikfar, B., Chaichian, S., & Ekhlasi‐Hundrieser, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-018-09764-z · Cited by 123
Xu, Q., Zhao, B., Ye, Y., Li, Y., Zhang, Y., Xiong, X., & Gu, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02137-8 · Cited by 119
Lin, X., Ouyang, S., Zhi, C., Li, P., Tan, X., Ma, W., Jiang, Y., Peng, T., Chen, X., Liang, L., et al. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109098 · Cited by 120
Takaku, T., Malide, D. A., Chen, J., Calado, R. T., Kajigaya, S., & Young, N. S. (2010) · Blood · doi:10.1182/blood-2010-02-268466 · Cited by 119
Shimada, K., Crother, T. R., Karlin, J. N., Chen, S., Chiba, N., Ramanujan, V. K., Vergnes, L., Ojcius, D. M., & Arditi, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021477 · Cited by 120
“The second signal, any one of a variety of unrelated entities—particulate matter [19], crystals [20], aggregated b -amyloid [21], extracellular ATP [22,23] and microbial toxins [24]—activates NLRP3.”
BackgroundTzeng, T.-C. J., Schattgen, S., Monks, B. G., Wang, D., Cerny, A., Latz, E., Fitzgerald, K. A., & Golenbock, D. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.011 · Cited by 125
“…diseases, including cryopyrin-associated periodic syndromes (Baroja-Mazo et al., 2014; Hoffman et al., 2001), gout (Martinon et al., 2006), Alzheimer’s disease (Halle et al., 2008; Heneka et al., 2013), and atherosclerosis (Duewell et al., 2010; Samstad et al., 2014; Sheedy et al., 2013).”
BackgroundSelf-citationTREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
Zysset, D., Weber, B., Rihs, S., Brasseit, J., Freigang, S., Riether, C., Banz, Y., Cerwenka, A., Simillion, C., Marques-Vidal, P. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13151 · Cited by 117
Recent Advances in Managing Atherosclerosis via Nanomedicine
Chan, C. K. W., Zhang, L., Cheng, C. K., Yang, H., Huang, Y., Tian, X. Y., & Choi, C. H. J. (2017) · Small · doi:10.1002/smll.201702793 · Cited by 118
Kim, J., Gee, H. Y., & Lee, M. G. (2018) · Journal of Cell Science · doi:10.1242/jcs.213686 · Cited by 131
Vulnerable Plaque, Characteristics, Detection, and Potential Therapies
Hafiane, A. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6030026 · Cited by 130
“Recent progress in this field has suggested that molecules upstream of IL-1β secretion, such as NLR Family Pyrin Domain-Containing 3 (NLRP3), mitochondrial cytidine/uridine monophosphate kinase-2 (CMPK2), or caspase-1/11, may provide further therapeutic targets for preventing atherosclerotic vascular disease [172,173].”
BackgroundRevisiting the Hallmarks of Aging to Identify Markers of Biological Age
Guerville, F., Barreto, P. D. S., Ader, I., Andrieu, S., Casteilla, L., Dray, C., Fazilleau, N., Guyonnet, S., Langin, D., Liblau, R., et al. (2020) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2019.50 · Cited by 122
“As cholesterol crystals and β-amyloid proteins can trigger assembly of inflammasome complexes, this pathway is involved in atherosclerosis lesion progression (80) and neuro-inflammation in AD (81,82).”
BackgroundMao, Y., Weng, J., Xie, Q., Wu, L., Xuan, Y., Zhang, J., & Han, J. (2024) · BMC Public Health · doi:10.1186/s12889-023-17556-w · Cited by 121
“…which include amplifying Toll-like receptor (TLR) signaling [63], activating NOD-, LRR-and pyrin domain-containing 3 (NLRP3) inflammasome [64], and stimulating the proliferation and maturation of monocytes and neutrophils in the bone marrow and spleen [65], thereby fueling the…”
BackgroundPrattichizzo, F., Nigris, V. D., Micheloni, S., Sala, L. L., & Ceriello, A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13488 · Cited by 118
“Inflammasome activation is a promising target to ameliorate LGI in T2DM and halt the progression of the atherosclerotic process.(28,36,37) Notably, BHB inhibits the NLRP3 inflammasome by preventing K efflux without undergoing oxidation in the Krebs cycle.”
BackgroundTargeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway
Xu, S., Chen, H., Ni, H., & Dai, Q. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.021 · Cited by 117
Cell pyroptosis in health and inflammatory diseases
Wu, Y., Zhang, J., Yu, S., Li, Y., Zhu, J., Zhang, K., & Zhang, R. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00998-3 · Cited by 125
“Many studies have shown that pyroptosis is not only involved in the development of atherosclerosis [10, 11], Alzheimer’s disease [12] and HIV-1 infection [13, 14] but also extensively involved in the occurrence and development of a variety of inflammatory diseases, including the progression of hepatitis to liver cance…”
BackgroundProcyanidin B2 inhibits NLRP3 inflammasome activation in human vascular endothelial cells
Yang, H., Xiao, L., Yuan, Y., Luo, X., Jiang, M., Ni, J., & Wang, N. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.10.001 · Cited by 118
Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma
Dunn, J. H., Ellis, L. Z., & Fujita, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.001 · Cited by 117
Cypryk, W., Nyman, T. A., & Matikainen, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02188 · Cited by 121
“These stimuli include cholesterol crystals (63, 64), MSU (22), calcium phosphate (65), and particulate β-glucans (66).”
BackgroundTuñón, J., Badimón, L., Bochaton‐Piallat, M., Cariou, B., Daemen, M. J. A. P., Egido, J., Evans, P. C., Hoefer, I. E., Ketelhuth, D. F. J., Lutgens, E., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy293 · Cited by 118
“These TLRs in addition prime the NLRP3 inflammasome through its activation by cholesterol crystals.(11) Also,”
BackgroundKruit, J. K., Wijesekara, N., Westwell-Roper, C. Y., Vanmierlo, T., de Haan, W., Bhattacharjee, A., Tang, R., Wellington, C. L., Lütjohann, D., Johnson, J. D., et al. (2012) · Diabetes · doi:10.2337/db11-1341 · Cited by 119
Inflammasomes and Metabolic Disorders: Old Genes in Modern Diseases
Robbins, G. R., Wen, H., & Ting, J. P. ‐. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.029 · Cited by 118
“Studies by Martinon et al. demonstrated that IL-1β and IL-18 maturation and release in response to MSU is dependent on NLRP3, ASC, CASPASE-1 and MyD88 using both human and mouse ex-vivo monocyte/macrophage cultures (Martinon et al., 2006).”
InfluentialPrimary Prevention of Atherosclerosis
Claudio Napoli, A., Crudele, V., Soricelli, A., Al-Omran, M. A., Vitale, N., Infante, T., & Mancini, F. P. (2012) · Circulation · doi:10.1161/circulationaha.111.085787 · Cited by 117
Palová-Jelínková, L., Dáňová, K., Drašarová, H., Dvořák, M., Funda, D. P., Fundová, P., Kotrbová-Kozak, A., Černá, M., Kamanová, J., Martin, S. F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062426 · Cited by 117
Li, X., Zhang, Y., Xia, M., Gulbins, E., Boini, K. M., & Li, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087552 · Cited by 116
Batulan, Z., Venu, V. K. P., Li, Y., Koumbadinga, G. A., Alvarez-Olmedo, D., Shi, C., & O’Brien, E. R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00285 · Cited by 120
High-Fat Diet Consumption Induces Microbiota Dysbiosis and Intestinal Inflammation in Zebrafish
Arias-Jayo, N., Abecia, L., Alonso‐Sáez, L., Ramirez‐Garcia, A., Rodriguez, A., & Pardo, M. Á. (2018) · Microbial Ecology · doi:10.1007/s00248-018-1198-9 · Cited by 118
Mouse models of atherosclerosis in translational research
Ilyas, I., Little, P. J., Liu, Z., Xu, Y., Kamato, D., Berk, B. C., Weng, J., & Xu, S. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.06.009 · Cited by 124
Inflammatory Mediators of Endothelial Dysfunction
Dri, E., Lampas, E., Lazaros, G. A., Lazarou, E., Theofilis, P., Tsioufis, C. P., & Tousoulis, D. (2023) · Life · doi:10.3390/life13061420 · Cited by 132
Oxylipins and metabolites from pyroptotic cells act as promoters of tissue repair
Mehrotra, P., Maschalidi, S., Boeckaerts, L., Maueröder, C., Tixeira, R., Pinney, J. J., Cardás, J. B., Sukhov, V., Incik, Y., Anderson, C. J., et al. (2024) · Nature · doi:10.1038/s41586-024-07585-9 · Cited by 122
“Inhibiting pyroptosis also provides benefits in certain non-infectious settings 10–12 .”
Role and function of macrophages in the metabolic syndrome
Bhargava, P., & Lee, C. (2012) · Biochemical Journal · doi:10.1042/bj20111708 · Cited by 117
This old heart: Cardiac aging and autophagy
Linton, P., Gurney, M. A., Sengstock, D. M., Mentzer, R. M., & Gottlieb, R. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.12.017 · Cited by 115
Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome
Du, Q., Wang, Q., Fan, H., Wang, J., Liu, X., Wang, H., Wang, Y., & Hu, R. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.017 · Cited by 114
Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice
Zhao, S., Gong, Z., Zhou, J., Tian, C., Gao, Y., Xu, C., Chen, Y., Cai, W., & Wu, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00536 · Cited by 120
Wu, D., Ren, P., Zheng, Y., Zhang, L., Xu, G., Xie, W., Lloyd, E. E., Zhang, S., Zhang, Q., Curci, J. A., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307648 · Cited by 114
Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation
Alippe, Y., Wang, C., Ricci, B., Xiao, J.-Q., Qu, C., Zou, W., Novack, D., Abu-Amer, Y., Civitelli, R., & Mbalaviele, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-07014-0 · Cited by 100
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
Seok, J. K., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01307-9 · Cited by 122
Mitochondria Related Cell Death Modalities and Disease
Tian, C., Liu, Y., Li, Z., Zhu, P., & Zhao, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.832356 · Cited by 113
“Oxidation of low lipoprotein (OX-LDL) activates NLRP3 in the plaque necrosis area formed early in atherosclerosis (Duewell et al., 2010).”
BackgroundSchneider, K. M., Bieghs, V., Heymann, F., Hu, W., Yildiz, D., Liao, L., Frissen, M., Ludwig, A., Gaßler, N., Pabst, O., et al. (2015) · Hepatology · doi:10.1002/hep.27982 · Cited by 112
Self-citationMyofibroblasts and lung fibrosis induced by carbon nanotube exposure
Dong, J., & Ma, Q. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0172-2 · Cited by 114
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Distéfano‐Gagné, F., Bitarafan, S., Lacroix, S., & Gosselin, D. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00709-6 · Cited by 115
The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications
Wang, X., Chen, L., Wei, J., Zheng, H., Zhou, N., Xu, X., Deng, X., Liu, T., & Zou, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02220-z · Cited by 132
Ma, Y., Wang, W., Zhang, J., Lu, Y., Wu, W., Yan, H., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035835 · Cited by 113
Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis
Luna‐Luna, M., Medina-Urrutia, A. X., Vargas‐Alarcón, G., Coss-Rovirosa, F., Vargas‐Barrón, J., & Pérez-Méndez, O. A. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.007 · Cited by 111
IKKα negatively regulates ASC-dependent inflammasome activation
Martin, B. N., Wang, C., Willette‐Brown, J., Herjan, T., Gulen, M. F., Zhou, H., Bulek, K., Franchi, L., Sato, T., Alnemri, E. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5977 · Cited by 116
Self-citationWang, Y., Han, Z., Fan, Y., Zhang, J., Chen, K., Gao, L., Zeng, H., Cao, J., & Wang, C. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000470822 · Cited by 113
Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
Rao, Z., Chen, X., Wu, J., Xiao, M., Zhang, J., Wang, B., Fang, L., Zhang, H., Wang, X., Yang, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02783 · Cited by 116
Silvis, M. J. M., Demkes, E. J., Fiolet, A. T. L., Dekker, M., Bosch, L., van Hout, G. P. J., Timmers, L., & de Kleijn, D. P. V. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10049-w · Cited by 115
“showed the importance of the NLRP3 inflammasome in the development and progression of atherosclerosis [29].”
BackgroundWang, L., Chen, Y., Li, X., Zhang, Y., Gulbins, E., & Zhang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12302 · Cited by 111
Activation of NLRP3 inflammasome by crystalline structures via cell surface contact
Hari, A., Zhang, Y., Tu, Z., Detampel, P., Stenner, M. D., Ganguly, A., & Shi, Y. (2014) · Scientific Reports · doi:10.1038/srep07281 · Cited by 111
Compan, V., Martín‐Sánchez, F., Baroja‐Mazo, A., López‐Castejón, G., Gomez, A. I., Verkhratsky, A., Brough, D., & Pelegrı́n, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1301676 · Cited by 116
Lim, R. S., Suhalim, J. L., Miyazaki‐Anzai, S., Miyazaki, M., Levi, M., Potma, E. O., & Tromberg, B. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018077 · Cited by 110
Oikonomou, E. K., Leopoulou, M., Theofilis, P., Antonopoulos, A. S., Siasos, G., Latsios, G., Mystakidi, V. C., Antoniades, C. A., & Tousoulis, D. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.07.027 · Cited by 117
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis
Hettwer, J., Hinterdobler, J., Miritsch, B., Deutsch, M.-A., Li, X., Mauersberger, C., Moggio, A., Braster, Q., Gram, H., Robertson, A. A. B., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab337 · Cited by 118
Caspase-1–mediated pathway promotes generation of thromboinflammatory microparticles
Rothmeier, A. S., Marchese, P., Petrich, B. G., Furlan-Freguia, C., Ginsberg, M. H., Ruggeri, Z. M., & Ruf, W. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79329 · Cited by 111
Neutrophil-macrophage communication in inflammation and atherosclerosis
Nahrendorf, M., & Świrski, F. K. (2015) · Science · doi:10.1126/science.aac7801 · Cited by 113
Hovland, A., Jonasson, L., Garred, P., Yndestad, A., Aukrust, P., Lappegård, K. T., Espevik, T., & Mollnes, T. E. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.038 · Cited by 113
Self-citationSelf-eating in the plaque: what macrophage autophagy reveals about atherosclerosis
Sergin, I., & Razani, B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.010 · Cited by 111
An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology
Ratsimandresy, R. A., Dorfleutner, A., & Stehlik, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00440 · Cited by 114
Greenhalgh, A. D., Brough, D., Robinson, E. M., Girard, S., Rothwell, N. J., & Allan, S. M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008557 · Cited by 111
Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation
Yabal, M., Calleja, D. J., Simpson, D. S., & Lawlor, K. E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-124r · Cited by 110
Inflammation, infection and atherosclerosis
Shah, P. K. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.01.004 · Cited by 111
Trained immunity in organ transplantation
Ochando, J., Fayad, Z. A., Madsen, J. C., Netea, M. G., & Mulder, W. J. M. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15620 · Cited by 113
“84 Therefore, it is plausible to hypothesize that trained macrophages contribute to allograft fibrosis and arterio‐ sclerosis, which promote chronic rejection.”
Zhang, S., Li, Z., Zhang, Y., Jin, C., Li, Y., Wu, F., Wang, W., Cui, Z. J., & Chen, G. (2021) · Advanced Science · doi:10.1002/advs.202003410 · Cited by 110
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Elrakaybi, A., Laubner, K., Zhou, Q., Hug, M. J., & Seufert, J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101549 · Cited by 118
Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy
Lin, H., Xiong, W. G., Fu, L., Yi, J., & Yang, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00305-3 · Cited by 137
Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target
Dénes, Á., Pinteaux, E., Rothwell, N. J., & Allan, S. M. (2011) · Cerebrovascular Diseases · doi:10.1159/000332205 · Cited by 111
Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification
Wen, C., Yang, X., Yan, Z., Zhao, M., Yue, X., Cheng, X., Zheng, Z., Guan, K., Dou, J., Xu, T., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.211 · Cited by 110
Olsen, I., & Yilmaz, Ö. (2016) · Journal of Oral Microbiology · doi:10.3402/jom.v8.30385 · Cited by 112
Malik, A. F., Hoque, R., Ouyang, X., Ghani, A., Hong, E., Khan, K., Moore, L. B., Ng, G., Munro, F., Flavell, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105152108 · Cited by 107
RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality
Meng, L., Jin, W., & Wang, X. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514730112 · Cited by 109
Nidorf, S. M., Fiolet, A. T. L., Eikelboom, J. W., Schut, A., Opstal, T. S. J., Bax, W. A., Budgeon, C. A., Tijssen, J. G. P., Mosterd, A., Cornel, J. H., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.09.011 · Cited by 112
The Role of Lipids and Lipoproteins in Atherosclerosis
Linton, M. F., Yancey, P. G., Davies, S. S., Jerome, W. G., Linton, E. F., Song, W., Doran, A. C., & Vickers, K. C. (2015) · Europe PMC (PubMed Central) · Cited by 108
Metadata
- Authors
- Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., Espevik, T., Lien, E., Fitzgerald, K. A., Rock, K. L., Moore, K. J., Wright, S. D., Hornung, V., & Latz, E.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- Michigan State University (US)
- University of Michigan (US)
- Ludwig-Maximilians-Universität München (DE)
- Norwegian University of Science and Technology (NO)
- CSL (Australia) (AU)
- University of Bonn (DE)
- Corresponding author
- Latz, Eicke
- ORCID
- Venue
- Nature
- Published
- 2010-04-01
- Volume
- 464
- Issue
- 7293
- Pages
- 1357-1361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2946640
- OpenAlex
- W1972483153
- Cited by
- 4,026
- References
- 31
- Citations by year
- 2026: 274 · 2025: 255 · 2024: 291 · 2023: 299 · 2022: 321 · 2021: 307 · 2020: 291 · 2019: 270 · 2018: 282 · 2017: 245 · 2016: 199 · 2015: 228 · 2014: 194 · 2013: 197 · 2012: 197
- FWCI
- 72.42
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-07-29)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL093262)
- National Institute of Allergy and Infectious Diseases (R01AI075318, R01AI083713)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- NLRP3 inflammasome, cholesterol crystals, atherogenesis, atherosclerosis, phagocytes, IL-1β, IL-1α, cathepsin B, cathepsin L, ASC, caspase-1, LDL receptor, apolipoprotein E deficiency, high-cholesterol diet
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cathepsin B, Cholesterol, Crystallization, Cytoskeletal Proteins, Diet, Atherogenic, Female, Humans, Inflammation, Interleukin-1, Lysosomes, Mice, Inbred C57BL, Peritoneal Cavity, Phagocytes, Receptors, LDL, Time Factors, Bone Marrow Transplantation, Interleukin-18, Atherosclerosis, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Cathepsin L
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
